Oligonucleotide Synthesis, Modification and Purification Services Market
To request for Customize Report – https://www.rootsanalysis.com/reports/304/request-sample.html
Key Inclusions
§ A detailed review of
the current status of the market with respect to oligonucleotide manufacturers
focused on research and diagnostic, and therapeutic applications. It features
information on the year of establishment, company size, scale of operation
(preclinical, clinical, and commercial), location of headquarters, number of
manufacturing facilities, along with their locations (country-wise), and
regulatory accreditations and certifications received by them, type of
oligonucleotide manufactured (antisense oligonucleotides, aptamers, decoys,
miRNA, shRNA, siRNA, specialty amidites, and others), type of offering (custom
synthesis, modification and purification), type of manufacturing service(s)
offered (process development and characterization, method validation and
testing, analytical development, sequencing capabilities, stability studies,
quality assurance and control, scale-up, fill/finish, downstream processing, regulatory
support, data analytics and reporting, and others), type of modification(s)
offered (amino modifiers, backbone modifications, fluorescent probes, dyes and
quenchers, modified bases, phosphorylation, thiol modifications, and others),
type of purification method(s) used (desalting, cartridge purification, HPLC,
ion exchange purification, PAGE, and others), and compliance to cGMP standards.
§ A company
competitiveness analysis, highlighting prominent oligonucleotide manufacturers for
research and diagnostic, and therapeutic applications, based on supplier
strength (which was calculated by considering the size of employee base of a
company and its experience in this field) and service strength (quantified
based on scale of operation, expertise in manufacturing different types of
oligonucleotides, type of offering, type of manufacturing service(s)
offered, type of modification(s) offered, type of purification method(s) used,
compliance to cGMP standards, as well as number and location of manufacturing
facilities).
§ Elaborate profiles of
key players that offer a diverse range of capabilities for custom synthesis,
modification and purification of oligonucleotides for use in research
and diagnostic, and therapeutic applications. Each profile includes an overview
of the company, its financial performance (if available), information
related to its service portfolio, manufacturing facilities, details on
partnerships, recent developments (expansions), and awards received by the
firm, as well as an informed future outlook.
§ An analysis of the
various partnerships pertaining to oligonucleotide manufacturing, which have
been established since 2014, based on several parameters, such as the year of
partnership, type of partnership, type of partner, most active players (in
terms of number of partnerships signed), and a geographical analysis.
§ An analysis of the
various expansion initiatives undertaken by service providers engaged in this
domain, in order to augment their respective oligonucleotide manufacturing
capabilities, over the period 2014-2019, taking into consideration several
relevant parameters, such as year of expansion, type of expansion (capability
expansion, capacity expansion, facility expansion and new facility), scale of
operation (preclinical, clinical and commercial), application (research and
manufacturing operations), and location of manufacturing facility.
§ A detailed analysis
of completed, ongoing and planned clinical research studies of various
oligonucleotide-based drug products, highlighting prevalent trends across
several relevant parameters, such as trial registration year, phase of
development, type of oligonucleotide, current trial
recruitment status, study focus area, key therapeutic areas (in terms of
number of trials undertaken / conducted), enrolled patient
population and trial location, and leading industry and non-industry players (in
terms of number of trials undertaken / conducted).
§ An estimate of the
overall, annual capacity for manufacturing oligonucleotides based on data
reported by industry stakeholders in the public domain; it highlights the
distribution of available oligonucleotide synthesis capacity on the basis of
company size (small, mid-sized, and large firms), scale of operation
(preclinical, clinical and commercial), and key geographical regions (North
America, Europe, Asia-Pacific and rest of the world).
§ An informed estimate
of the annual commercial demand for oligonucleotide-based drug products (in
kilograms), taking into account the marketed oligonucleotide products; the
analysis takes into consideration the target patient population, dosing
frequency and dose strength, of the aforementioned products. The annual
clinical demand for oligonucleotide-based drug products was also estimated,
taking into account ongoing and planned clinical trials.
§ A discussion on
affiliated trends, key drivers and challenges, under an elaborate SWOT
framework, which are likely to impact the industry’s evolution, including a
Harvey ball analysis, highlighting the relative effect of each SWOT parameter
on the overall industry.
§ A survey analysis
featuring inputs solicited from various experts who are directly / indirectly
involved in providing custom synthesis, modification and purification services
for oligonucleotides.
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html
The
report also features the likely distribution of the current and forecasted
opportunity across important market segments, mentioned below:
§ Custom Manufacturing
§ Large-scale Manufacturing
§
- Type of Oligonucleotides Manufactured
§ Antisense Oligonucleotides
§ miRNAs
§ shRNAs
§ siRNAs
§ Other
Oligonucleotides
- Scale of Operation
§ Clinical
§ Commercial
- Purpose of Production
§ In-house
§ Outsourced
- Target Therapeutic
Area
§ Autoimmune Disorders
§
Cardiovascular Disorders
§
Genetic Disorders
§
Infectious Diseases
§
Metabolic Disorders
§
Neuromuscular Disorders
§
Oncological Disorders
§
Ophthalmic Disorders
§ Other Therapeutic Areas
- Size of
manufacturer
§ Small
§ Mid-sized
§ Large
- Key Geographical Region
§ North
America
§ Europe
§ Asia-Pacific
and Rest of the World
§ Transcripts of
interviews held with the following senior level representatives of stakeholder
companies
§
Joachim Bertram (Chief
Scientific Officer and Managing Director, IBA Lifesciences)
§ Tobias
Pohlmann (Founder and Managing Director, BianoScience)
To request
for Customize Report – https://www.rootsanalysis.com/reports/oligonucleotide-synthesis/request-customization.html
Key
Questions Answered
§
Who are the leading manufacturers of oligonucleotides for
use in research, diagnostic and therapeutic applications?
§
What are the preferred custom synthesis, modification and
purification methods used for oligonucleotides?
§
What are the key challenges faced by oligonucleotide
manufacturers?
§
What kind of partnership models are commonly adopted by
industry stakeholders?
§
What are the recent expansion initiatives undertaken by
service providers within this domain?
§
What is the annual clinical and commercial demand for
oligonucleotides?
§
What is the current, installed manufacturing capacity for
oligonucleotides?
§
What percentage of oligonucleotide manufacturing operations
are outsourced to service providers?
§ What
are the opportunities in emerging markets for oligonucleotide manufacturing?
§
How is the current and future market opportunity likely to
be distributed across key market segments?
§
What are the anticipated future trends related to
oligonucleotide manufacturing?
You may also be
interested in the following titles:
1. China
Biopharmaceutical Contract Manufacturing Market, 2020-2030
2. Pharmaceutical
Continuous Manufacturing Market, 2020-2030
3.
Peptide
Therapeutics: Contract API Manufacturing Market, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Comments
Post a Comment